Dr Sophie Otter : Clinical oncology

Home
Dr Sophie Otter

Bupa Platinum consultant
Fee assured
Verified account
Open Referral network

Overview

Specialises in

Colon

Urology

Offers

Face-to-face consultations
Video and telephone consultations

About me

I am an experienced Consultant Clinical Oncologist specialising in the treatment of Prostate, Bladder and Colorectal cancers.

I studied Medicine at the University of Cambridge graduating in 2004 and receiving distinctions in Medicine, Surgery and Pathology. Following medical school, I worked in General Medicine at Guy's and St Thomas' before Oncology training at The Royal Marsden, The Royal Sussex and The Royal Surrey Hospitals. I have been a consultant at The Royal Surrey since 2019 and during that time have also been Chief of Service for Oncology.

I completed an MD(Res) at the University of Surrey in Complex adaptive radiotherapy planning for cervical cancers and have published widely in international journals.

I am passionate about cutting edge radiotherapy for pelvic tumours using the MR Linac which allows high doses of radiotherapy to be delivered whilst minimising the side effects.

I also provide treatment with intensity modulated radiotherapy (IMRT) and brachytherapy as well as systemic therapies such as chemotherapy, targeted therapies and hormone treatment.

Areas of interest

Prostate Cancer; Bladder Cancer; Colorectal Cancer; Prostate Brachytherapy; Intensity Modulated Radiotherapy, MRI-guided radiotherapy

Medical secretaries

Krystina Ewin-Lambert
krystina.ewin-lambert@nuffieldhealthpartners.com

About me

Current NHS consultant posts held

I am a Consultant Clinical Oncologist working at the Royal Surrey County Hospital in Guildford. I also provide outreach services to Ashford and St Peter's Hospitals.

Research interests

My research has been focused on image guided radiotherapy with the intention on improving cure rates whilst minimising side effects from pelvic radiotherapy. I also have a special research interest in the role of brachytherapy in pelvic malignancies.

Awards received

Patricia McGregor Travel Fellowships Fund 2012
ESTRO 37 Junior Brachytherapy Travel Grant 2018
ESTRO 38 Junior Brachytherapy Travel Grant 2019
Keith Durrant Memorial Fellowship, RCR 2019

Publications

For an up-to-date list of publications please see https://www.researchgate.net/profile/Sophie_Otter

PUBLICATIONS:
1. Otter S, Ring, A. Outcomes following adjuvant therapy for HER2-positive early breast cancer in the elderly. Expert Rev. Anticancer Ther. 10(8), 1265-1272 (2010)
2. Otter S, Schick U, Gulliford S, Lal P, Franceschini D, Newbold K, Nutting C, Harrington, K, Bhide, S. Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions. Int J Radiat Oncol Biol Phys. 1;93(3):507-15 (2015).
3. Otter S, Franklin A, Ajaz M, Stewart A. Improving the efficiency of image guided brachytherapy in cervical cancer." J Contemp Brachytherapy. 8(6): 557-565 (2016).
4. Otter S, Coates A, Franklin A, et al: Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer. Brachytherapy, 2018
5. Otter S, Chong I, Kalaitzaki R, Tait D. Which patients with locally advanced pancreatic cancer treated with induction chemotherapy are most likely to benefit from post-induction chemoradiotherapy? Int J Hepatobiliary Pancreat Dis 2018;
6. Otter S, Whittaker S, Chatterjee J, Stewart A. The Human Papillomavirus as a Common Pathogen in Head and Neck, Cervical and Anal Cancers. Clin Oncol (R Coll Radiol) 31:81-90, 2019
7. Otter S, Chatterjee J, Stewart A, Micheal A. The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer. Clin Oncol (R Coll Radiol) 31:834-843.
2019
8. Otter S, Stewart A, Devlin P. Modern Brachytherapy. Hematol Oncol Clin North Am. Dec;33(6):1011-1025, 2019

BOOK CHAPTERS
1. Otter S, Holloway, C, Devlin P, Stewart A. Clinical Applications of Brachytherapy-Low Dose Rate and Pulse Dose Rate (chapter 26). Perez & Brady’s Principles and Practice of Radiation Oncology. 7th edition. 2019
2. Otter S, Holloway C, O’Farrell D, Devlin D, Stewart A. Brachytherapy (chapter 20). Clinical Radiation Oncology. Gunderson and Tepper. 5th edition.

My qualifications & training

Qualifications

MBBChir (Medical degree) University of Cambridge 2004
B.A.(Hons) Medicine University of Cambridge 2002
MSc Oncology (Distinction) University of London 2014
MA Medicine University of Cambridge 2006
MD (Res) University of Surrey 2019

Additional training

FRCR Royal College of Radiologists 2012
MRCP (UK) Royal College of Physicians 2008

GMC registration

Reference number 6113504

Professional bodies (positions held - last 3 yrs)

Advisory editor Clinical Oncology (journal associated with RCR) 2020

Details of entry to specialist register

Completion of Specialist Training Clinical Oncology , 2019

Affiliations / memberships

ESTRO member
RCR member

My private practice

Practice hours

Practice
Day
Hours
Appt Bookings

Genesiscare Surrey
Wednesday
09:00 - 13:00
01483 555914

Stirling RoadSurrey Research ParkGUILDFORDGU2 7RF
Friday
13:00 - 16:00
01483 555914

Post treatment communication

Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

Nuffield Health Guildford Hospital (1-5)
X0008
Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (1-5)

GenesisCare, Surrey (1-5)
X6772
Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)

GenesisCare, Surrey (1-5)
X6950
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (1-5)
X6544
Delivery of a fraction of Intensity Modulated Radiotherapy (IMRT) including Image Guided Radiotherapy (IGRT) on a megavoltage machine - (1-5)

GenesisCare, Surrey (1-5)
Show All (6 )...

Report this page Print page

Finder

Note:

Dr Sophie Otter

Clinical oncology 06113504

Specialises in

Offers

About me

Areas of interest

Medical secretaries

Current NHS consultant posts held

Research interests

Awards received

Publications

Qualifications

Additional training

GMC registration

Professional bodies (positions held - last 3 yrs)

Details of entry to specialist register

Affiliations / memberships

Practice hours

Practice

Day

Hours

Appt Bookings

Post treatment communication

Information for healthcare professionals (Bupa patients only, last 12 months)